Related Experiment Video
Updated: Jul 8, 2026

Megakaryocyte Differentiation and Platelet Formation from Human Cord Blood-derived CD34+ Cells
Published on: December 27, 2017
Identification of platelet-derived growth factor D in human chronic allograft nephropathy
Gang Liu1, Siribha Changsirikulchai, Kelly L Hudkins
1Institute of Nephrology, Peking University, First Hospital, 100034 Beijing, China.
Abstract:
Chronic allograft nephropathy (CAN), a descriptive term denoting chronic scarring injury of the renal parenchyma and vasculature in allograft kidneys arising from various etiologies including chronic rejection, is the most common cause of late allograft failure, but mediators of this progressive injury largely remain unknown. We hypothesized that platelet-derived growth factor D (PDGF-D) and its specific receptor PDGF-Rbeta may be an important mediator in the pathogenesis of CAN and, hence, sought to identify its expression in this setting. Allograft nephrectomies demonstrating CAN, obtained from patients with irreversible transplant kidney failure (n = 15), were compared with renal tissues without prominent histopathological abnormalities (n = 18) and a series of renal allograft biopsies demonstrating acute vascular rejection (AVR) (n = 12). Antibodies to PDGF-D and PDGF-Rbeta were used for immunohistochemistry. Double and triple immunohistochemistry was used to identify cell types expressing PDGF-D. PDGF-D was widely expressed in most neointimas in arteries exhibiting the chronic arteriopathy of CAN and only weakly expressed in a small proportion of sclerotic arteries in the other 2 groups. Double and triple immunolabeling demonstrated that the neointimal cells expressing PDGF-D were alpha-smooth muscle actin-expressing cells, but not infiltrating macrophages or endothelial cells. PDGF-Rbeta expression evaluated in serial sections was localized to the same sites where neointimal PDGF-D was expressed. PDGF-Rbeta was expressed in interstitial cells more abundantly in the CAN group compared with the normal and AVR groups, without demonstrable colocalization of PDGF-D. PDGF-D is present in the neointima of the arteriopathy of CAN, where it can engage PDGF-Rbeta to promote mesenchymal cell migration, proliferation, and neointima formation. PDGF-D may engage the PDGF-Rbeta to promote interstitial injury in chronic allograft injury, but its sources within the interstitium were unidentified.
Insights
Platelet-derived growth factor D (PDGF-D) is present in arteries affected by chronic allograft nephropathy (CAN), potentially driving injury. PDGF-D may also contribute to interstitial damage in kidney transplants.
Area of Science:
- Nephrology
- Immunology
- Vascular Biology
Background:
- Chronic allograft nephropathy (CAN) is the primary cause of late kidney transplant failure.
- The specific mediators driving CAN progression remain largely unknown.
Purpose of the Study:
- To investigate the role of platelet-derived growth factor D (PDGF-D) and its receptor PDGF-Rbeta in the pathogenesis of CAN.
- To identify the cellular sources and localization of PDGF-D and PDGF-Rbeta in CAN.
Main Methods:
- Immunohistochemistry was used to detect PDGF-D and PDGF-Rbeta expression in kidney allograft nephrectomies from patients with CAN, normal renal tissues, and biopsies with acute vascular rejection (AVR).
- Double and triple immunohistochemistry identified cell types expressing PDGF-D.
Main Results:
- PDGF-D was significantly expressed in the neointima of arteries with CAN-associated arteriopathy.
- Neointimal cells expressing PDGF-D were identified as alpha-smooth muscle actin-positive cells.
- PDGF-Rbeta was co-localized with PDGF-D in the neointima and more abundant in interstitial cells in the CAN group.
Conclusions:
- PDGF-D, acting via PDGF-Rbeta in the neointima, likely promotes mesenchymal cell proliferation and neointima formation in CAN.
- PDGF-D may also contribute to interstitial injury in chronic allograft injury, though its interstitial source is unclear.